Author:
Chollet P,Amat S,Belembaogo E,Curé H,de Latour M,Dauplat J,Le Bouëdec G,Mouret-Reynier M-A,Ferrière J-P,Penault-Llorca F
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Adjuvant Therapy for Breast Cancer (2000) NIH consensus statement. 17(4): 1–35
2. Amat S, Penault-Llorca F, Cure H, Le Bouedec G, Achard JL, Van Praagh I, Feillel V, Mouret-Reynier MA, Dauplat J, Chollet P (2002) Scarff–Bloom–Richardson (SBR) grading: a pleiotropic marker of chemosensitivity in invasive ductal breast carcinomas treated by neoadjuvant chemotherapy. Int J Oncol 20: 791–796
3. Balslev I, Axelsson CK, Zedeler K, Rasmussen BB, Carstensen B, Mouridsen HT (1994) The Nottingham prognostic index applied to 9,149 patients from the studies of the Danish breast Cancer Cooperative Group (DBCG). Breast Cancer Res Treat 32: 281–290
4. Belembaogo E, Feillel V, Chollet P, Cure H, Verrelle P, Kwiatkowski F, Achard JL, Le Bouëdec G, Chassagne J, Bignon Y-J, de Latour M, Lafaye C, Dauplat J (1992) Neoadjuvant chemotherapy in 126 operable breast cancers. Eur J Cancer 28A(4/5): 896–900
5. Cameron DA, Anderson ED, Levack P, Hawkins RA, Anderson TJ, Leonard RC, Forrest AP, Chetty U (1997) Primary systemic therapy for operable breast cancer – 10-year survival data after chemotherapy and hormone therapy. Br J Cancer 76: 1099–1105
Cited by
38 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献